Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer-论文-万方医学网

Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer

导出原文传递

翻译打印收藏纠错

作者： Gandhi, Khushboo A. ^[1] ; Joshi, Amit ^[2] ; Mehta, Parsshava ; Gurjar, Murari ; Rane, Pallavi ; Sharma, Jyoti ; Patil, Anand ; Nookala, Manjunath ; Noronha, Vanita ; Prabhash, Kumar ; Gota, Vikram

作者单位： Adv Ctr Treatment Res & Educ Canc ACTREC,Tata Mem Ctr TMC ^[1] Dept Med Oncol,Tata Mem Hosp ^[2]

关键词 Sunitinib Therapeutic drug monitoring Objective response SU12662 Toxicity Receiver operating characteristic curve KINASE INHIBITORS PHASE-II CARCINOMA IMATINIB OUTCOMES TUMORS

发布时间 2022-07-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer

相似文献

相关期刊

检索历史清除